Related Experiment Video
Updated: May 1, 2026

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
Published on: May 4, 2018
Serum antimicrobial peptides in patients with familial Mediterranean fever
Abdurrahman Tufan1, Rıdvan Mercan1, Ozge Tugce Pasaoglu2
1Gazi University, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey.
Abstract:
Familial Mediterranean fever (FMF) is characterized by recurrent inflammation of serosal and synovial membranes. Despite the fact that it is a genetic disease, environmental factors, including infections, are shown to be triggering factors associated with the precipitation of attacks in FMF. Antimicrobial peptides (AMPs) are components of innate immunity which exert antimicrobial activity against many microorganisms. Human AMPs; cathelicidin (LL37) and defensins have immunomodulatory properties and are involved in the pathogenesis of many inflammatory disorders. Hence, we investigated serum AMPs in 23 newly diagnosed FMF patients. Blood samples were obtained at baseline, 6 months after initiation of colchicine and during an attack. Twenty-four healthy individuals constituted the control group. The concentrations of LL37, alpha-1, beta-1 and beta-2 defensins were determined by ELISA. Serum AMPs did not change during attacks and did not correlate with acute phase reactants. However, serum LL37 and defensins were found to be remarkably higher in FMF patients compared to healthy individuals both at baseline and 6 months after initiation of colchicine therapy which suggest that AMPs might have a role in the pathogenesis of FMF.
Insights
Antimicrobial peptides (AMPs), including cathelicidin (LL37) and defensins, are elevated in Familial Mediterranean Fever (FMF) patients. These immune components may play a role in FMF pathogenesis, even after treatment.
Area of Science:
- Immunology
- Genetics
- Rheumatology
Background:
- Familial Mediterranean Fever (FMF) involves recurrent inflammation of serosal and synovial membranes.
- While genetic, FMF attacks can be triggered by environmental factors like infections.
- Antimicrobial peptides (AMPs) are key innate immunity components with immunomodulatory roles in inflammation.
Purpose of the Study:
- To investigate serum concentrations of specific antimicrobial peptides (AMPs) in newly diagnosed Familial Mediterranean Fever (FMF) patients.
- To compare AMP levels in FMF patients with healthy controls and assess changes during attacks and after colchicine therapy.
Main Methods:
- Serum samples collected from 23 newly diagnosed FMF patients at baseline, during attacks, and 6 months post-colchicine treatment.
- Serum samples from 24 healthy individuals served as controls.
- Concentrations of cathelicidin (LL37), alpha-1, beta-1, and beta-2 defensins measured using ELISA.
Main Results:
- Serum AMP levels did not significantly change during FMF attacks or correlate with acute phase reactants.
- FMF patients exhibited significantly higher serum concentrations of LL37 and defensins compared to healthy controls.
- Elevated AMP levels persisted in FMF patients even 6 months after initiating colchicine therapy.
Conclusions:
- Serum LL37 and defensins are markedly elevated in FMF patients, suggesting a potential role in the disease's pathogenesis.
- AMPs may be involved in the underlying inflammatory processes of FMF, independent of acute attack status or standard treatment.
Related Concept Videos
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Myocarditis II: Clinical Features and Diagnostic Tests
Clinical Significance of Antibiotic Resistance
Myocarditis III: Medical Management
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:

